Literature DB >> 10655147

Imbalance in corneal redox state during herpes simplex virus 1-induced keratitis in rabbits. Effectiveness of exogenous glutathione supply.

C Nucci1, A T Palamara, M R Ciriolo, L Nencioni, P Savini, C D'Agostini, G Rotilio, L Cerulli, E Garaci.   

Abstract

A significant decrease in the antioxidant glutathione (GSH) was found in the corneal tissue of rabbits with Herpes Simplex 1 (HSV-1)-induced keratitis. Such a decrease was due to a loss of the reduced species, since no increase in its oxidized form was observed. Topical administration of purified GSH was able to reduce the virus titre in corneal tissue and, at the same time, was effective in reducing the severity and progression of keratitis and conjunctivitis. This effect was paralleled by a partial recovery in the corneal GSH content. In vitro experiments performed on HSV-1 infected corneal-derived rabbit cells showed that exogenous GSH reduced virus titre in the supernatant of infected cells. These results are in agreement with our previous findings that an oxidative environment, due to GSH depletion, is necessary for virus replication and suggest that topical GSH treatment could be considered as complementary therapy in HSV-1-induced keratitis. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10655147     DOI: 10.1006/exer.1999.0782

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  26 in total

1.  Accumulation of oxidized proteins in Herpesvirus infected cells.

Authors:  Shomita S Mathew; Patrick W Bryant; April D Burch
Journal:  Free Radic Biol Med       Date:  2010-05-02       Impact factor: 7.376

2.  Elucidation of the block to herpes simplex virus egress in the absence of tegument protein UL16 reveals a novel interaction with VP22.

Authors:  Jason L Starkey; Jun Han; Pooja Chadha; Jacob A Marsh; John W Wills
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

Review 3.  Ultraviolet radiation: cellular antioxidant response and the role of ocular aldehyde dehydrogenase enzymes.

Authors:  Satori A Marchitti; Ying Chen; David C Thompson; Vasilis Vasiliou
Journal:  Eye Contact Lens       Date:  2011-07       Impact factor: 2.018

Review 4.  Corneal ulceration in pediatric patients: a brief overview of progress in topical treatment.

Authors:  Serina Stretton; Usha Gopinathan; Mark D P Willcox
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 5.  Viral product trafficking to mitochondria, mechanisms and roles in pathogenesis.

Authors:  Chad D Williamson; Roberta L DeBiasi; Anamaris M Colberg-Poley
Journal:  Infect Disord Drug Targets       Date:  2012-02

6.  Herpes simplex virus type 1 infection induces oxidative stress and the release of bioactive lipid peroxidation by-products in mouse P19N neural cell cultures.

Authors:  Jerry H Kavouras; Emese Prandovszky; Klara Valyi-Nagy; S Krisztian Kovacs; Vaibhav Tiwari; Maria Kovacs; Deepak Shukla; Tibor Valyi-Nagy
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

7.  Herpes simplex virus type 1 encephalitis is associated with elevated levels of F2-isoprostanes and F4-neuroprostanes.

Authors:  Dejan Milatovic; Yueli Zhang; Sandra J Olson; Kathleen S Montine; L Jackson Roberts; Jason D Morrow; Thomas J Montine; Terence S Dermody; Tibor Valyi-Nagy
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

8.  The immune response to herpes simplex virus encephalitis in mice is modulated by dietary vitamin E.

Authors:  Patricia A Sheridan; Melinda A Beck
Journal:  J Nutr       Date:  2008-01       Impact factor: 4.798

Review 9.  Antioxidant defenses in the ocular surface.

Authors:  Ying Chen; Gaurav Mehta; Vasilis Vasiliou
Journal:  Ocul Surf       Date:  2009-10       Impact factor: 5.033

10.  Regulated interaction of tegument proteins UL16 and UL11 from herpes simplex virus.

Authors:  Pooja Chadha; Jun Han; Jason L Starkey; John W Wills
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.